Monogram Technologies (NASDAQ: MGRM) is a medical device company developing a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company delivered its first surgical robot in November 2023, will market its solutions to international markets in 2024, and anticipates 510(k) submission in the second half of 2024.The company has $10.1 million in cash, and we believe the company will be funded throughout 2024. We believe MGRM stock to be undervalued at this time with several significant potential catalysts within the next 12 months.

18 Jun 2024
MGRM: Monogram reports 1st quarter 2024 financial results and provided updates on the development of its mB s Total Knee Arthroplasty (TKA) System.

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
MGRM: Monogram reports 1st quarter 2024 financial results and provided updates on the development of its mB s Total Knee Arthroplasty (TKA) System.
Monogram Technologies (NASDAQ: MGRM) is a medical device company developing a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company delivered its first surgical robot in November 2023, will market its solutions to international markets in 2024, and anticipates 510(k) submission in the second half of 2024.The company has $10.1 million in cash, and we believe the company will be funded throughout 2024. We believe MGRM stock to be undervalued at this time with several significant potential catalysts within the next 12 months.